| Trial ID: | L5718 |
| Source ID: | NCT00315952
|
| Associated Drug: |
Exubera
|
| Title: |
Study to Estimate the Effects of Inhaled Versus Intravenous (IV) Infusion of Human Insulin in Subjects With Type 1 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 1 Diabetes Mellitus
|
| Interventions: |
DRUG: Exubera
|
| Outcome Measures: |
Primary: To perform positron emission tomography (PET) imaging of [18F]-fluoro-deoxy-glucose (FDG) uptake by muscle, following administration of a single dose of inhaled compared to infused insulin in volunteers with type 1 diabetes | Secondary: To determine overnight rates of glucose production and plasma glucose after a single pre-dinner dose of inhaled compared to IV infused insulin in volunteers with type 1 diabetes
|
| Sponsor/Collaborators: |
Sponsor: University of Pittsburgh | Collaborators: Pfizer
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
12
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2006-04
|
| Completion Date: |
2006-12
|
| Results First Posted: |
|
| Last Update Posted: |
2008-02-18
|
| Locations: |
University of Pittsburgh, Pittsburgh, Pennsylvania, 15213, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00315952
|
